国泰君安创新医药混合发起A(014157)
2025-04-23
0.8231
-1.2478%
| 报告期 |
基金净值 |
股票 |
国债及现金 |
可转债 |
企业债 |
金融债 |
其他债券 |
其他投资 |
贷方余额 |
| 2025-03-31 | 17,323.92 | 14,916.38 | 2,776.46 | 0.00 | 0.00 | 0.00 | 0.00 | 250.20 | 0.00 |
| 2024-12-31 | 23,202.90 | 15,829.09 | 7,812.43 | 0.00 | 0.00 | 0.00 | 0.00 | 35.79 | 0.00 |
| 2024-09-30 | 13,046.15 | 11,332.47 | 1,730.60 | 0.00 | 0.00 | 0.00 | 0.00 | 6.87 | 0.00 |
| 2024-06-30 | 10,631.09 | 8,767.75 | 1,883.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.48 | 0.00 |
| 2024-03-31 | 10,709.28 | 9,171.53 | 1,562.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.69 | 0.00 |
| 2023-12-31 | 11,891.56 | 9,925.71 | 1,995.21 | 0.00 | 0.00 | 0.00 | 0.00 | 2.33 | 0.00 |
| 2023-09-30 | 12,336.01 | 10,747.60 | 1,607.99 | 0.00 | 0.00 | 0.00 | 0.00 | 3.36 | 0.00 |
| 2023-06-30 | 11,779.54 | 9,899.97 | 1,917.01 | 0.00 | 0.00 | 0.00 | 0.00 | 6.24 | 0.00 |
| 2023-03-31 | 18,937.42 | 14,974.70 | 4,591.43 | 0.00 | 0.00 | 0.00 | 0.00 | 76.11 | 0.00 |
| 2022-12-31 | 3,325.28 | 2,575.93 | 757.10 | 0.00 | 0.00 | 0.00 | 0.00 | 1.05 | 0.00 |
| 2022-09-30 | 2,875.71 | 2,279.88 | 602.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 0.00 |
| 2022-06-30 | 3,129.11 | 2,462.14 | 673.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2022-03-31 | 3,098.39 | 2,461.24 | 645.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
